AIR Global CEO Details Strategy After Navigating H1 Supply Shocks

AIR Global (NASDAQ: AIIR), a flavored shisha manufacturer, successfully navigated significant supply chain disruptions in the first half of the year to post revenue growth, and now has its sights set on the U.S. market for its next phase of expansion, according to its chief executive.

Navigating Supply Chain Disruption

The company, which went public in May via a SPAC merger, faced immediate headwinds as conflict in the Middle East disrupted a shipping route that historically handled about 70% of its volumes. Despite this, AIR Global reported a 3.7% year-over-year increase in first-half revenue, CEO Stuart Brazier told Investing.com in a recent interview.

Brazier attributed the performance to a deliberate strategy of prioritizing its highest-value markets, such as Saudi Arabia and the United States. "Given the relative price inelasticity of our product, we were also able to pass on the cost inflation," he said, noting this resulted in a 14% positive price/mix variance that more than compensated for lower shipment volumes.

To mitigate future risks, the company has established alternate shipping routes and is constructing a new manufacturing facility in Romania, expected to be operational in 2027. Brazier confirmed that AIR Global's full-year revenue growth guidance of 4%-6% remains intact.

U.S. Market and Growth Products

While its core Al Fakher shisha brand remains central, the company is pinning future growth on new products, particularly its Crown Switch rechargeable pod vape system. Brazier highlighted the U.S. as a "tremendous whitespace opportunity," citing an estimated $7 billion domestic e-cigarette market, a significant figure compared to AIR's roughly $400 million revenue in 2025.

Ad

Entry into the U.S. market is contingent on regulatory review by the Food and Drug Administration (FDA). Brazier described recent FDA enforcement guidance as "encouraging" and a "constructive development for responsible operators." He noted that an independent study showed Crown Switch aerosols had materially lower levels of certain harmful constituents compared to some FDA-authorized products, which he believes is a key differentiator.

The next-generation product category is still in its infancy, generating just $2.2 million in H1 revenue with an adjusted EBITDA loss of $7.9 million.

SPAC Listing and Financials

AIR Global went public through a combination with a special purpose acquisition company (SPAC), a path Brazier said offered a "more predictable path to Nasdaq." The listing contributed to a reported H1 net loss of $81.8 million, which stands in contrast to its positive adjusted EBITDA of $71.7 million for the period.

Management attributed the large net loss primarily to non-recurring, listing-related items, including $48.2 million tied to equity issued at listing and $47.7 million in cash costs related to the IPO. Brazier stated that the company expects to be judged on its business fundamentals and execution over time. "Our first half demonstrated resilience despite significant disruption," he said.